Download A phase 1/2 study of an adjuvanted varicella-zoster virus - E

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Transcript
Phase 1/2a
Study Design I
Edward A. Stadtmauer et al. Blood 2014;124:2921-2929
 Observer blind – Randomized – Placebo controlled
N = 121 pts
 121 pts were randomized - 1:1:1:1 – 1 pt not vaccinated
 Taking into account underlying disease
Patient Characteristics
Age>18
MM or B/T cell NHL or HL or AML
Autologous HCT in the previous 50-70 days
Women of non-child-bearing potential
Exclusion Criteria
Previous VZV/HZ vaccination
Hx of VZV infection within the previous 12 months
Exposure to VZV post HCTx
Immunoglobulin Rx or vaccination post HCTx
Acute infection upon enrollment
Contraindication to vaccination (ie allergies)
Receiving any investigational product 30 days ago – throughout the whole study
Document related concepts

Hygiene hypothesis wikipedia, lookup

Innate immune system wikipedia, lookup

Psychoneuroimmunology wikipedia, lookup

Sociality and disease transmission wikipedia, lookup

Childhood immunizations in the United States wikipedia, lookup

Immunomics wikipedia, lookup

DNA vaccination wikipedia, lookup

Neonatal infection wikipedia, lookup

West Nile fever wikipedia, lookup

Hepatitis B wikipedia, lookup

Chickenpox wikipedia, lookup

Molecular mimicry wikipedia, lookup

Immunosuppressive drug wikipedia, lookup

Globalization and disease wikipedia, lookup

Polyclonal B cell response wikipedia, lookup

Henipavirus wikipedia, lookup

Infection control wikipedia, lookup

Blood type wikipedia, lookup

Human cytomegalovirus wikipedia, lookup

Herd immunity wikipedia, lookup

Immunocontraception wikipedia, lookup

Vaccination wikipedia, lookup

Vaccine wikipedia, lookup

Vaccination policy wikipedia, lookup